| Cas No.: | 299442-43-6 |
| Chemical Name: | NKY80 |
| Synonyms: | 5(6H)-Quinazolinone, 2-amino-7-(2-furanyl)-7,8-dihydro-;2-AMINO-7-FURAN-2-YL-7,8-DIHYDRO-6H-QUINAZOLIN-5-ONE;NKY 80;2-Amino-3,5-dihydro-7-(3-pyridinylmethyl)-4H-pyrrolo[3,2-d]pyrimidin-4-one;2-amino-7-(3-pyridinylmethyl)-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidine-4-one;2-amino-7-(furan-2-yl)-7,8-dihydro-5(6H)-quinazolinone;2-amino-7-(furanyl)-7,8-dihydro-5(6H)-quinazolinone;2-amino-7-(pyridin-3-ylmethyl)-3,5-dih;9-(3-Pyridylmethyl)-7H-9-deazaguanine;AC1Q6I9H;BCX 34;BCX-34;CHEBI:228309;CHEMBL311300;PELDESINE;Peldesine (USAN);Peldesine [USAN];2-Amino-7-(2-furanyl)-7,8-dihydro-5(6H)-quinazolinone;NKY80;CHEMBL1456284;2-amino-7-(2-furyl)-7,8-dihydro-5(6H)-quinazolinone;299442-43-6;Oprea1_089733;2-amino-7-(2-furanyl)-7,8-dihydro-6H-quinazolin-5-one;GTPL5233;ALBB-004836;LS-01767;cid_2772368;NKY-80;2-azanyl-7-(furan-2-yl)-7,8-dihydro-6H-quinazolin-5-one;Q27087944;AKOS016042252;HMS1672K18;CS-0025286;SMR000070575;GLXC-04493;MFCD02026323;adenylyl cyclase type V Inhibitor;SR-01000433245-1;AKOS000301518;DTXSID101214613;DA-66119;2-amino-7-(2-furyl)-7,8-dihydroquinazolin-5(6H)-one;2-amino-7-(furan-2-yl)-7,8-dihydroquinazolin-5(6H)-one;SCHEMBL6045417;NKY80, >=98% (HPLC);2-amino-7-(2-furyl)-7,8-dihydro-6H-quinazolin-5-one;BDBM95032;STK028106;2-amino-7-(furan-2-yl)-7,8-dihydro-6H-quinazolin-5-one;CCG-16635;2-amino-7-(furan-2-yl)-5,6,7,8-tetrahydroquinazolin-5-one;MLS000061319;HY-103195;HMS2349F13;2-Amino-7-(2-furanyl)-7,8-dihydro-5(6H)quinazolinone; 2-Amino-7-(furan-2-yl)-5,6,7,8-tetrahydroquinazolin-5-one; 2-Amino-7-(furan-2-yl)-7,8-dihydro-6H-quinazolin-5-one; 2-Amino-7-furan-2-yl-7,8-dihydro-6H-quinazolin-5-one;;Oprea1_144808;Adenylyl Cyclase Type V Inhibitor, NKY80;SR-01000433245;J-017706 |
| SMILES: | O1C=CC=C1C1CC(C2=CN=C(N)N=C2C1)=O |
| Formula: | C12H11N3O2 |
| M.Wt: | 229.234642267227 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A potent, selective adenylyl cyclase AC5/6 inhibitor with IC50 of 7.7/17 uM, respectively; displays little to no activity for other AC isoforms (IC50>100 uM); blocks both BAPTA-AM-stimulated cAMP formation and renin release in primary cultures of juxtaglomerular cells. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
